Clinical Trials Search

Title Intervention Sponsor Status
Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer Antitumor B Medical College of Wisconsin Active, not recruiting
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer Carvedilol, Laboratory Biomarker Analysis, Patient Observation SWOG Cancer Research Network Recruiting
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer Radiation Therapy, Questionnaire Administration, Quality-of-Life Assessment, Laboratory Biomarker Analysis, Hypofractionated Radiation Therapy Alliance for Clinical Trials in Oncology Active, not recruiting
Treating Pain in Children With Cancer: Pain Buddy Pain Buddy University of California, Irvine Recruiting
Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer Dexamethasone, Laboratory Biomarker Analysis, Netupitant/Palonosetron Hydrochloride, Olanzapine, Placebo, Prochlorperazine, Quality-of-Life Assessment University of Rochester NCORP Research Base Recruiting
Dexamethasone in Controlling Dyspnea in Patients With Cancer Dexamethasone, Questionnaire Administration, Placebo M.D. Anderson Cancer Center Active, not recruiting
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery Endoxifen Hydrochloride, Placebo Administration, Questionnaire Administration National Cancer Institute (NCI) Active, not recruiting
Lifestyle, Exercise, and Nutrition Study Early After Diagnosis Dietary/Physical Activity intervention, Usual Care Yale University Active, not recruiting
Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients Magnetic Resonance Imaging, Biospecimen Collection, Laboratory Biomarker Analysis City of Hope Medical Center Recruiting
MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer MUC1 Peptide-Poly-ICLC Vaccine, Laboratory Biomarker Analysis National Cancer Institute (NCI) Active, not recruiting